Columbia, MD, United States of America

Jian-kang Jiang

This inventor holds 10 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Cincinnati Children's Hospital Medical Center, The Brigham and Women's Hospital, Inc.. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian-kang Jiang. Retrieved from https://idiyas.com/inventor/jian-kang-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jian-kang Jiang

Introduction

Jian-kang Jiang is a prominent inventor based in Columbia, MD, known for his significant contributions to the field of biomedical research. With a total of 10 patents to his name, Jiang has made remarkable strides in developing innovative solutions for various medical conditions.

Latest Patents

Among his latest patents, Jiang has developed ALK2 inhibitors and methods for inhibiting BMP signaling. This invention provides small-molecule inhibitors of BMP signaling, which can be utilized to modulate cell growth, differentiation, proliferation, and apoptosis. These compounds are particularly useful for treating diseases associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders. Additionally, they may aid in treating conditions such as Sjögren's syndrome and diffuse intrinsic pontine glioma (DIPG). Another notable patent involves substituted imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors. This invention includes compounds and compositions that can be used to treat various diseases, including head and neck squamous cell carcinoma (HNSCC) and blood disorders. The patent also explores synergistic combinations of a BCL2 inhibitor with an IRAK inhibiting compound.

Career Highlights

Jiang has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the Children's Hospital Medical Center. His work in these institutions has significantly contributed to advancements in medical research and treatment methodologies.

Collaborations

Throughout his career, Jiang has collaborated with notable colleagues, including Craig J. Thomas and Douglas S. Auld. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Jian-kang Jiang's contributions to the field of biomedical research through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…